Filgrastim Completed Phase 1 / 2 Trials for Aplastic Anemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00011830Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission